指南与共识主动脉疾病

肾下腹主动脉瘤修复的SVS指南与现实实践差距扩大

Increasing disparity between Society for Vascular Surgery guidelines for infrarenal abdominal aortic aneurysm repair and real-world practice.
指南 / 共识 · J Vasc Surg · 2020-09-01

基于Vascular Study Group of New England数据库2003-2015年5314例肾下腹主动脉瘤修复患者,研究发现40%的修复在直径<5.5 cm时进行,且EVAR用于<5.5 cm的比例从2003年33%增至2015年46%(P<.05),与SVS指南推荐的5.5 cm阈值差距扩大。

要点

  • 40%的iAAA修复在<5.5 cm时进行,其中EVAR占75%。
  • EVAR用于<5.5 cm的比例从2003年33%升至2015年46%(P<.05)。
  • EVAR组30天死亡率为1.11%,开放组为3%。

核心结论

  • 尽管SVS指南建议<5.5 cm的iAAA应监测而非修复,但VSGNE数据库中低于该阈值的修复比例不断增加。
  • 可能需要重新审视当前的iAAA修复指南。

研究设计与样本

  • 基于Vascular Study Group of New England数据库的回顾性队列研究,纳入2003-2015年5314例iAAA修复患者(开放1538例,EVAR 3776例)。
  • 排除非择期病例(破裂或有症状)、合并髂动脉瘤及关键数据缺失者。

主要发现

  • 40%(2110/5314)的患者修复时动脉瘤<5.5 cm,其中EVAR占75%(1581/2110),开放占25%(529/2110)。
  • EVAR用于<5.5 cm的比例从2003年33%增至2015年46%(P<.05),年均增加1.1%。
  • 开放修复小动脉瘤的比例也有非统计学显著增加(年均0.7%,P=.759)。
  • EVAR组30天死亡率为1.11%(<5.0 cm为0.54%,≥5.0但<5.5 cm为0.91%,≥5.5 cm为1.55%),开放组为3%(分别为2.88%、1.79%、3.77%),两组死亡率随时间无显著变化。

关键数值与推荐

  • SVS指南推荐肾下腹主动脉瘤修复的最小直径阈值为5.5 cm。
  • 研究按直径分类:≥5.5 cm;<5.5 cm但≥5.0 cm;<5.0 cm。

临床怎么用

  • 临床实践中需关注小于指南阈值的iAAA修复趋势,权衡EVAR低死亡率与小动脉瘤修复的长期获益。
  • 应结合患者个体情况与最新证据,审慎决定小动脉瘤的修复时机。

局限性

  • 研究为回顾性数据库分析,可能存在选择偏倚。
  • 未报告小动脉瘤修复的具体原因及长期随访结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The current Society for Vascular Surgery (SVS) guidelines, based on randomized controlled trials published more than a decade ago, recommend a minimum threshold diameter of 5.5 cm for infrarenal abdominal aortic aneurysm (iAAA) repair. It is unknown whether practice patterns with respect to size of repair have changed since the publication of these guidelines. We aimed to evaluate the real-world practice of vascular surgeons in our region with respect to iAAA size at the time of repair, whether this has changed over the past 12 years and if any changes were associated with the repair type, open vs endovascular. METHODS: The Vascular Study Group of New England (VSGNE) database was used to identify all patients who received iAAA repair between 2003 and 2015. The primary end point was to quantify the annual percentage of iAAAs repaired in different size categories (≥5.5 cm; <5.5 cm but ≥5.0 cm; <5.0 cm) over the study time period and by type of repair. The secondary end points were morbidity and mortality in these groups. We excluded nonelective cases (ruptured or symptomatic), patients with coexisting iliac artery aneurysms, and those missing critical data. RESULTS: A total of 5314 patients with iAAA repairs (1538 open, 3776 endovascular) were identified in the VSGNE database during the study period. In 40% (2110 of 5314) of patients, repair was performed for aneurysms <5.5 cm, with endovascular aneurysm repair (EVAR) comprising 75% (1581 of 2110) and open 25% (529 of 2110). More EVARs were performed for <5.5 cm in 2015 (46%) compared with 2003 (33%) (P < .05, n - 1 χ2) with an average increase of 1.1%/y. There was also a non-statistically significant increase in open repair of small aneurysms (0.7%/y; P = .759). Overall, 30-day mortality was 1.11% in the EVAR group (0.54% in <5.0 cm, 0.91% in ≥5.0 but <5.5 cm, and 1.55% in ≥5.5 cm), compared with 3% in the open group (2.88%, 1.79%, and 3.77%, respectively) with no significant change in mortality in either group over time. CONCLUSIONS: Despite the SVS guidelines suggesting surveillance rather than repair of iAAA <5.5 cm, an increasing proportion of repairs in the VSGNE database were performed below that threshold. The reasons for this are likely multifactorial and might include a lesser complexity and lower operative mortality for smaller aneurysms and markedly improved third- and fourth-generation stent graft technology with possibly better long-term survival. As such, it may be time to re-examine the current guidelines for iAAA repair.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Schlieder I, Kontopidis I, Blackwood S, et al. Increasing disparity between Society for Vascular Surgery guidelines for infrarenal abdominal aortic aneurysm repair and real-world practice. J Vasc Surg. 2020. PMID: 32889077. doi:10.1016/j.jvs.2020.08.116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。